"Gender and Race as Prognostic Factors in Patients Treated with Rituximab for B-Cell Non-hodgkin Lymphoma" by Mendel Goldfinger

Selected Works of Santiago Aparo

Follow Contact

Article

Gender and Race as Prognostic Factors in Patients Treated with Rituximab for B-Cell Non-hodgkin Lymphoma

Blood / American Society of Hematology (ASH) 55th Annual Meeting (2013)

Mendel Goldfinger, Montefiore Medical Center
Santiago Aparo, Montefiore Medical Center
Krishna Gundabolu, Mayo Clinic
Stefan K Barta, Montefiore Medical Center

Link

Disciplines

Medicine and Health Sciences and
Immunology and Infectious Disease

Publication Date

December, 2013

Citation Information

Mendel Goldfinger, Santiago Aparo, Krishna Gundabolu and Stefan K Barta. "Gender and Race as Prognostic Factors in Patients Treated with Rituximab for B-Cell Non-hodgkin Lymphoma" Blood / American Society of Hematology (ASH) 55th Annual Meeting Vol. 122 Iss. 21 (2013) p. 3053 - 3053
Available at: http://works.bepress.com/santiago-aparo/18/